Funding for HIV network extended CMAJ 1997;156:1524 The federal government has extended stable funding for the Canadian HIV Trials Network (CTN) from March 1998 to the year 2000. The announcement was welcomed by Dr. Martin Schechter, national director of the CTN, who thanked Health Minister David Dingwall for recognizing that clinical research "cannot be turned on and off like a tap." The CTN also announced that it has entered into a large-scale international clinical research trial of 1300 HIV-positive volunteers (including 400 Canadians) to compare 2 protease inhibitors: nelfinavir, which is an investigational agent under review in the US, and ritonavir, which is licensed for use in Canada. Send a letter to the editor responding to this article Envoyez une lettre à la rédaction au sujet de cet article | CMAJ June 1, 1997 (vol 156, no 11) / JAMC le 1er juin 1997 (vol 156, no 11) |